CRT 2026

Discussion

Moderator(s)

• 

  Alexandre A. Abizaid, MD, PhD

  Full Professor of Cardiology; Director of Invasive Cardiology
  Incor
  SÃO PAULO, Sao Paulo, Brazil

  Disclosure(s): No financial relationships to disclose
• 

  Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

  Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes; Director of Interventional Cardiovascular Research and Clinical Trials; Director of Women’s Heart and Vascular Center at Mount Sinai Heart
  Icahn School of Medicine at Mount Sinai, New York
  New York, New York, United States

  Disclosure(s): Abbott, Alleviant Medical, Chiesi, Concept Medical, Cordis, CPC Clinical Research, Daiichi Sankyo, Duke, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Medtronic, NewAmsterdam Pharma, Novartis, Novo Nordisk Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (Vice President, BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Stock Options [in privately held companies] (Ongoing); Population Health Research Institute (PHRI), Protembis GmbH, Radcliffe, RM Global Bioaccess Fund Management, Sanofi US Services, Inc. ;: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): No Fees (Ongoing)
• 

  Ron Waksman, MD, MSCAI

  Director, Cardiovascular Research and Advanced Education
  MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
  Washington, District of Columbia, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Sandeep Basavarajaiah, MBBS, MD, MRCP, FESC

  Consultant Cardiologist
  National Health Service

  Disclosure(s): No financial relationships to disclose
• 

  Antonio Colombo, MD

  Professor of Cardiology
  Humanitas IRCCS
  Milan, Lombardia, Italy

  Disclosure(s): No financial relationships to disclose
• 

  Bernardo Cortese, MD, FESC, FSCAI

  Director of Coronary Program
  University Hospitals
  Cleveland, Ohio, United States

  Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Sahil A. Parikh, MD, FSCAI

  Associate Professor of Medicine
  Columbia University Irving Medical Center
  New York, New York, United States

  Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Advanced NanoTherapies: Stock Options [in privately held companies] (Ongoing); AVS: Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Encompass vascular: Stock Options [in privately held companies] (Ongoing); Fastwave: Grant/Research Support (Ongoing); Inari/Stryker: Consulting Fees (e.g., advisory boards) (Ongoing); Medinol: Grant/Research Support (Ongoing); Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); R3 Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Aloke V. Finn, MD

  President CVPath/Prof. Of Medicine University of Maryland
  CVPath
  Gaithersburg, Maryland, United States

  Disclosure(s): Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Ulf Teichgräber, MD

  Chair
  University Hospital Jena, Friedrich-Schiller-University
  Jena, Thuringen, Germany

  Disclosure(s): Concept Medical: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)